
Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
To own IMAX, you need to believe premium theatrical experiences will keep attracting audiences and that the company can translate that demand into growing cash flows and installations. The record China results for Spider-Man: Brand New Day support the near term catalyst of stronger box office contribution per screen, but they do not remove the key risk that IMAX remains heavily dependent on a steady pipeline of tentpole releases to sustain performance.
The most relevant recent announcement here is IMAX’s Q2 2026 earnings, where revenue rose to US$102.84 million and net income to US$15.4 million. Against that backdrop, the Spider-Man performance in China reinforces how big titles can amplify those financial trends, but it also highlights how concentrated IMAX’s fortunes are around a relatively small number of blockbuster-dependent box office moments.
Yet this strength in China also sits alongside a risk investors should be aware of if blockbuster supply or audience habits begin to shift...
Read the full narrative on IMAX (it's free!)
IMAX's narrative projects $513.8 million revenue and $134.2 million earnings by 2029.
Uncover how IMAX's forecasts yield a $46.82 fair value, a 6% downside to its current price.
Compared with consensus, the most pessimistic analysts were assuming about US$498.6 million of revenue and US$96.8 million of earnings by 2029, which shows how sharply views can differ and why this strong Spider-Man opening in China could influence how you weigh those more cautious expectations against the possibility that IMAX’s premium footprint and tentpole reliance evolve in ways the pre news forecasts did not fully capture.
Explore 3 other fair value estimates on IMAX - why the stock might be worth 6% less than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com